PADI1
Protein-arginine deiminase type-1
Also known as: HPAD10, PAD1, PADI1_HUMAN, PDI, PDI1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9ULC6
- Gene
- PADI1
- Ensembl
- ENSG00000142623
- Chromosome
- 1
- Canonical length
- 663 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes a member of the peptidyl arginine deiminase family of enzymes, which catalyze the post-translational deimination of proteins by converting arginine residues into citrullines in the presence of calcium ions. The family members have distinct substrate specificities and tissue-specific expression patterns. The type I enzyme is involved in the late stages of epidermal differentiation, where it deiminates filaggrin and keratin K1, which maintains hydration of the stratum corneum, and hence the cutaneous barrier function. This enzyme may also play a role in hair follicle formation. This gene exists in a cluster with four other paralogous genes. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
663 residues, UniProt reviewed canonical sequence.
>Q9ULC6|PADI1
1 MAPKRVVQLS LKMPTHAVCV VGVEAHVDIH SDVPKGANSF RVSGSSGVEV FMVYNRTRVK
61 EPIGKARWPL DTDADMVVSV GTASKELKDF KVRVSYFGEQ EDQALGRSVL YLTGVDISLE
121 VDTGRTGKVK RSQGDKKTWR WGPEGYGAIL LVNCDRDNHR SAEPDLTHSW LMSLADLQDM
181 SPMLLSCNGP DKLFDSHKLV LNVPFSDSKR VRVFCARGGN SLSDYKQVLG PQCLSYEVER
241 QPGEQEIKFY VEGLTFPDAD FLGLVSLSVS LVDPGTLPEV TLFTDTVGFR MAPWIMTPNT
301 QPPEELYVCR VMDTHGSNEK FLEDMSYLTL KANCKLTICP QVENRNDRWI QDEMEFGYIE
361 APHKSFPVVF DSPRNRGLKD FPYKRILGPD FGYVTREIPL PGPSSLDSFG NLDVSPPVTV
421 GGTEYPLGRI LIGSSFPKSG GRQMARAVRN FLKAQQVQAP VELYSDWLSV GHVDEFLTFV
481 PTSDQKGFRL LLASPSACLK LFQEKKEEGY GEAAQFDGLK HQAKRSINEM LADRHLQRDN
541 LHAQKCIDWN RNVLKRELGL AESDIVDIPQ LFFLKNFYAE AFFPDMVNMV VLGKYLGIPK
601 PYGPIINGRC CLEEKVQSLL EPLGLHCIFI DDYLSYHELQ GEIHCGTNVR RKPFPFKWWN
661 MVPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PADI1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 84 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 84 nTPM
- vagina: 15 nTPM
- cervix: 9.1 nTPM
- salivary gland: 8.5 nTPM
- tonsil: 4.1 nTPM
- skin: 3.7 nTPM
Single-cell type
- papillary tip epithelial cells: 11 nCPM
- esophageal apical cells: 5.9 nCPM
- microglia: 3 nCPM
- loop of henle epithelial cells: 2.5 nCPM
- salivary duct cells: 1.8 nCPM
- other brain neurons: 1.1 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- pons: 0.3 nTPM
- hypothalamus: 0.2 nTPM
- medulla oblongata: 0.2 nTPM
- cerebellum: 0.1 nTPM
- cerebral cortex: 0.1 nTPM
- midbrain: 0.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PADI1.
Disease | ImmuneIEDB
Conditions an epitope on PADI1 was assayed in.
- rheumatoid arthritis B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.14
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.05
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein-arginine deiminase
- Cupredoxin
- Protein-arginine deiminase, C-terminal
- Protein-arginine deiminase (PAD), N-terminal
- Protein-arginine deiminase (PAD), central domain
- Protein-arginine deiminase, central domain superfamily
- PAD, N-terminal domain superfamily
- Protein-arginine deiminase (PAD)
- Protein-arginine deiminase (PAD) N-terminal domain
- Protein-arginine deiminase (PAD) middle domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PADI1 as an antibody target. Whether an autoantibody or antibody against PADI1 could matter depends on whether native PADI1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PADI1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PADI1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...